From the labto the hospital

Cancer Genomics

Grup de genòmica del càncer a Vall d'Hebron

The Cancer Genomics groups focuses on determining somatic mutations in tumour genomes to identify patients who might participate in clinical trials. 


The Cancer Genomics group is also working on identifying somatic mutations involved in the mechanisms of sensitivity or resistance to PI3K inhibitors in breast cancers and gliomas. It is working in close collaboration with basic and clinical researchers from the genomics service in Vall d'Hebron Institute of Oncology.

Visit the research group’s page

Healthcare specialisations
Teaching units